financetom
Business
financetom
/
Business
/
What's Going On With Xpeng Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Xpeng Stock Today?
Aug 29, 2024 9:23 AM

Xpeng ( XPEV ) has reportedly achieved a significant milestone with its proprietary AI chip, confirming long-standing rumors.

Xpeng ( XPEV ) shares are trading relatively flat on Wednesday, falling over 56% in the past year.

During the launch event for its new model, the Mona M03, the Chinese electric vehicle manufacturer revealed that its first AI chip, Turing, successfully completed its tape-out on August 23, reported CnEV Post.

He Xiaopeng, the company’s CEO, stated that the Turing chip will be utilized in Xpeng’s electric vehicles, robots, and flying cars.

Tape-out is a technical term in integrated circuit design that describes the process of converting a circuit design into a chip ready for production. Once tape-out is successfully completed, the chip prototype can enter mass production, provided it passes further testing.

Also Read: China Slams Canada’s 100% Tariffs On Chinese EVs After Trudeau Administration Follows In The Footsteps Of US And EU: ‘Typical Trade Protectionism’

The Turing chip is specifically designed for L4 autonomous driving and boasts three times the computing power of the current autonomous driving chip used by Xpeng ( XPEV ), He mentioned.

Although he did not specify it directly, Xpeng’s current autonomous driving chip is Nvidia’s Drive Orin X, which offers 254 TOPS (tera operations per second) of computing power per chip.

Price Action: XPEV shares are trading lower by 0.44% to $7.97 premarket at last check Wednesday.

See Also: 

Tesla's Optimus On Display At Beijing Robot Conference: Chinese Robotics Industry Gains Momentum With New Innovations

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioNTech says collaboration with Pfizer remains unchanged
BioNTech says collaboration with Pfizer remains unchanged
Nov 13, 2025
FRANKFURT, Nov 13 (Reuters) - BioNTech said on Thursday that its collaboration with Pfizer ( PFE ) has not changed, when asked to comment on a report that Pfizer ( PFE ) is looking to sell its stake in the German biotech firm. We continue to have a close and strong collaboration, a spokesperson said in a statement, adding that...
Nortech Systems Q3 net loss narrows due to restructuring efforts 
Nortech Systems Q3 net loss narrows due to restructuring efforts 
Nov 13, 2025
Overview * Nortech Q3 2025 net sales decline 2.9% yr/yr to $30.5 mln * Net loss narrows to $146,000 in Q3 2025 from $739,000 in Q3 2024 * Adjusted EBITDA rises to $1.3 mln in Q3 2025 from $0.1 mln in Q3 2024 Outlook * Company highlights AS9100:D certification at Monterrey facility enhancing aerospace offerings * Nortech ( NSYS )...
DiamondRock Hospitality to Transfer Listing to Nasdaq From NYSE
DiamondRock Hospitality to Transfer Listing to Nasdaq From NYSE
Nov 13, 2025
08:14 AM EST, 11/13/2025 (MT Newswires) -- DiamondRock Hospitality ( DRH ) said Thursday it will voluntarily transfer its class A common shares listing to Nasdaq from the New York Stock Exchange. The company said it anticipates its common shares to start trading on the Nasdaq Global Select Market on Dec. 1, under the current DRH ticker. ...
Genetic medicines firm MeiraGTx misses Q3 revenue expectations, net loss widens
Genetic medicines firm MeiraGTx misses Q3 revenue expectations, net loss widens
Nov 13, 2025
Overview * MeiraGTx ( MGTX ) Q3 revenue misses analyst expectations, declining significantly from last year * Company enters strategic collaboration with Eli Lilly, including $75 mln upfront payment * Net loss widens to $50.5 mln in Q3, driven by increased R&D expenses Outlook * Company anticipates Phase 2 data for AAV-hAQP1 in early 2027 * MeiraGTx ( MGTX )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved